文献速递关节外科小儿骨科

高髋中心重建非骨水泥全髋关节置换术治疗发育性髋关节发育不良:至少13年随访研究

Developmental Dysplasia Treated With Cementless Total Hip Arthroplasty Utilizing High Hip Center Reconstruction: A Minimum 13-Year Follow-up Study.
PubMed 文献 · J Arthroplasty · 2018-04-30

单中心连续104例(123髋)发育性髋关节发育不良患者采用高髋中心技术非骨水泥全髋关节置换术,随访13年无失访,仅1例因股骨松动翻修,聚乙烯磨损率低且与高髋中心无关联,中位HHS为91.9分。

要点

  • 高髋中心技术非骨水泥全髋关节置换术治疗发育性髋关节发育不良13年随访临床结果优良。
  • 聚乙烯磨损率低(均值3±19 μm/y),且与高髋中心重建无关联(P=.852)。
  • Crowe II-IV组HHS从4年至13年显著下降(P<.001),但82%患者13年时仍高于80分。

核心结论

  • 该髋臼杯设计与高交联聚乙烯内衬组合在发育性髋关节发育不良各程度及高髋中心重建患者中,13年随访显示出与原发性骨关节炎全髋关节置换术相似的优良临床结果。

研究设计与样本

  • 单中心连续系列104例患者(123髋),采用高髋中心技术、非骨水泥髋臼壳和高交联内衬的全髋关节置换术,术前及随访至13年收集影像学资料,4年和13年时评估Harris髋关节评分。

主要发现

  • 无患者失访,1例因股骨松动行翻修。
  • 20%患者出现放射透亮线,与高髋中心无关联(P=.560);无患者发生骨溶解。
  • 所有患者磨损率低(均值3±19 μm/y),与高髋中心无关联(P=.852)。
  • 13年时Harris髋关节评分中位数91.9(四分位距84.8-97.0)。
  • Crowe II-IV组Harris髋关节评分从4年至13年有统计学显著下降(P<.001),但82%患者13年时仍高于80分;非发育不良及Crowe I组Harris髋关节评分无纵向变化(P=.243)。

关键数值与推荐

  • 发育不良程度采用Crowe分型评估。
  • 放射透亮线见于20%患者,与高髋中心无关联(P=.560)。
  • 磨损率均值3±19 μm/y,与高髋中心无关联(P=.852)。
  • 13年Harris髋关节评分中位数91.9(四分位距84.8-97.0)。
  • Crowe II-IV组HHS从4年至13年下降有统计学显著差异(P<.001),82%患者13年时仍高于80分;非发育不良及Crowe I组无纵向变化(P=.243)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The primary aim of this study was to determine the clinical outcomes at 13-year follow-up of patients diagnosed with developmental dysplasia of the hip and subsequently treated with total hip arthroplasty (THA). The secondary aim was to investigate the effect of hip center location on clinical outcomes and polyethylene wear. METHODS: We reviewed data from a consecutive series of 104 patients (123 hips) from a single center. Patients were treated with THA with the high hip center (HHC) technique using cementless acetabular shells and highly cross-linked liners. Radiographs were collected preoperatively and through 13-year follow-up to assess degree of dysplasia (Crowe classification), component positioning, occurrence of bone resorption, and polyethylene wear. The Harris Hip Score (HHS) was administered at 4 and 13 years. RESULTS: No patients were lost to follow-up, and one was revised for femoral loosening. Radiolucency was seen in 20% of patients and was not associated with HHC (P = .560). No patients developed osteolysis. The wear rate was low for all patients (mean: 3 ± 19 μm/y) and not associated with HHC (P = .852). The median 13-year HHS was 91.9 (interquartile range: 84.8-97.0). There was a statistically significant decline from the 4- to 13-year HHS (P < .001) for the Crowe II-IV group, although 82% of these patients remained above 80 points at 13 years. The nondysplastic and Crowe I group showed no longitudinal change in HHS (P = .243). CONCLUSION: This cup design and highly cross-linked polyethylene liner combination demonstrates excellent clinical outcomes, similar to THA for primary osteoarthritis, through 13-year follow-up in patients with various degrees of developmental dysplasia of the hip and HHC reconstructions.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Galea VP, Laaksonen I, Donahue GS, et al. Developmental Dysplasia Treated With Cementless Total Hip Arthroplasty Utilizing High Hip Center Reconstruction: A Minimum 13-Year Follow-up Study. J Arthroplasty. 2018. PMID: 29803578. doi:10.1016/j.arth.2018.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。